Dmitry Popov
Founder at Maxwell Asset Management LLC (Private Equity)
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Alexander Alexandrov | M | - |
MYR GmbH
 MYR GmbH BiotechnologyHealth Technology MYR GmbH engages in operating an biotechnology company. It focuses on the development and commercialization of therapeutics for the treatment of chronic hepatitis B (HBV) and D (HDV) infections. The company was founded by Joern Moeller and Alexander Alexandrov in 2010 and is headquartered in Bad Homburg, Germany. | 14 years |
| Alexander Polinsky | M | 67 |
Maxwell Asset Management LLC (Private Equity)
 Maxwell Asset Management LLC (Private Equity) Investment ManagersFinance Maxwell Asset Management LLC /Private Equity/ (Maxwell Asset Management) is the private equity and venture capital subsidiary of Maxwell Capital Group LLC. The firm was founded by Dmitry Popov in 2008. It is headquartered in Moscow, Russia with an additional office in Boston, USA. | - |
| Alexey V. Eliseev | M | - |
Maxwell Asset Management LLC (Private Equity)
Maxwell Asset Management LLC (Private Equity) Investment ManagersFinance Maxwell Asset Management LLC /Private Equity/ (Maxwell Asset Management) is the private equity and venture capital subsidiary of Maxwell Capital Group LLC. The firm was founded by Dmitry Popov in 2008. It is headquartered in Moscow, Russia with an additional office in Boston, USA. | - |
| Chris Maxwell Wiltshire | M | - |
Maxwell Asset Management LLC (Private Equity)
Maxwell Asset Management LLC (Private Equity) Investment ManagersFinance Maxwell Asset Management LLC /Private Equity/ (Maxwell Asset Management) is the private equity and venture capital subsidiary of Maxwell Capital Group LLC. The firm was founded by Dmitry Popov in 2008. It is headquartered in Moscow, Russia with an additional office in Boston, USA. | - |
| Norbert Dinauer | M | - |
MYR GmbH
MYR GmbH BiotechnologyHealth Technology MYR GmbH engages in operating an biotechnology company. It focuses on the development and commercialization of therapeutics for the treatment of chronic hepatitis B (HBV) and D (HDV) infections. The company was founded by Joern Moeller and Alexander Alexandrov in 2010 and is headquartered in Bad Homburg, Germany. | - |
Connections Chart
Multi-company connection
Statistics
| Country | Connections | % of total |
|---|---|---|
| Russia | 3 | 60.00% |
| Germany | 2 | 40.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Dmitry Popov
- Personal Network
